Disc Medicine scores $50 mln Series A
Cambridge, Massachusetts-based Disc Medicine, a hematology company, has raised $50 million in Series A financing. Novo Holdings A/S led the round with participation from Access Biotechnology and Atlas Venture.
29 October 2019•1 min read
